Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2001; 47(3): 58-63

Estimationof some fibrinolytic chain haemostasis system parameters prognosticimportance at abdominal delivery

A.N. Savchuk, M.sH. Gamisonia, A.I. Kizim, T.N. Platonova

    A. V. Palladins Institute of biochemistry National Academy of Sciences ofUkraine, Kiev



Abstract

Complex analysis of pregnant women haemostasis system before and after caesarian section allowed find the coagulation system activation. It was shown the thrombic markers accumulation, AT III and protein C levels decrease. Also change of ratio fibrinolytic system components was exposed. Definition of t-PA and PAI-1 activities can be used as prognostic markers of the fibrinolytic chain haemostasis system disfunction.

Full text: (PDF, in Ukrainian)

References

  1. СПИСОК ЛІТЕРАТУРИ
  2. Биохимические компоненты свертывания крови. // Под ред. Макарова В.А. - Сверд- ловск, Изд-во Урал. Ун-та, 1990. – 210 с.
  3. Веремеенко К.Н., Кизим А.И., Терзов А.И. и др. Влияние ингибиторов плазмы кровина активность сериновых и цистеиновых протеиназ // Укр.биохим.журн. – 1998. 70, № 6. – С.35-42.
  4. Веремеєнко К.М. Генетичний поліморфізм альфа-1-інгібітора протеїназ і його діаг- значення // Лаб. Діагностика. – 1997. - №1. – С.5-10.
  5. Веремеєнко К.М., Кізім О. И., Досенко О.И. A2-макроглобулін: структура, фізіоло-гічна роль і клінічне значення // Там же – 2000. –№2. – С.3-8.
  6. Голота В.Я., Гамісонія М.Ш., Платонова Т.М., Макогоненко Є.М. Діагностика пре-тромботичного стану за допомогою сучасних коагулологічних тестів в акушерськійпрактиці // Там же – 1998. - №3. – С.15-18.
  7. Платонова Т.Н., Савчук А.Н., Ровинская И.Н. и др. Определение уровня тканевогоактиватора плазминогена и растворимого фибрина в плазмах больных при различ-ных патологиях // Там же – 2000. – N 2. – С.15-17.
  8. Сучасні методи лабораторної діагностики внутрішньосудинного мікрозсідання крові(методичні рекомендації). К.,– 1994. – 23 с.
  9. Bellart J., Gilabert R., Fontcuberta J. Et al. Coagulation and fibrinolytic parameters innormal pregnancy and in pregnancy complicated by intrauterine growth retardation // Amer. J. Perinatol. – 1998. – Feb; 15(2). – P.81-85.
  10. 9. Catz EG., Speir WA Jr. Alpha 1-Antitrypsin deficiency // South. Med.J. – 1984. –Apr; 77(4). – P.479-483.
  11. 10. Cerneca F., Ricci G., Simeone R. et al. Coagulation and fibrinolysis changes in normalpregnancy. Increased levels of procoagulants and reduced levels of inhibitors duringpregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis //Eur. J. Obstet. Gynecol. Reprod. Biol. – 1997. – May; 73(1). – P.31-36. Значимість деяких показників фібринолітичної системиA. V. Palladins Institute of biochemistry National Academy of Sciences of Kiev
  12. ISSN 0201-8489 Фізіол. журн., 2001, Т. 47, № 3 63
  13. Chandler W., Stratton J. Laboratory evaluation of fibrinolysis in patiens with a historyof myocardial infarction // Amer. J. Clin. Pathol. – 1994. – 102, N2. – P.248-252.
  14. Clark P., Greer IA., Walker ID. Interaction of the protein C/protein S anticoagulant system,the endothelium and pregnancy // Blood Rev. – 1999. – Sep; 13(3). – P. 127-146.
  15. de Fouw NJ., de Jong YF., Haverkate F., Bertina RM. Activated protein C increasesfibrin clot lysis by neutralization of plasminogen activator inhibitor—no evidence for acofactor role of protein S // Thromb. Haemost. – 1988. – Oct; 60(2). – P.328-333.
  16. Eriksson E., Ranby M., Gyzander E. et al. Determination of plasminogen activatorinhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulatedassay // Thromb. Res. – 1988. – 50(3). – P.91-101.
  17. Estelles A., Gilabert J., Aznar J. Et al. Changes in the plasma levels of type 1 and type2 plasminogen activator inhibitors in normal pregnancy and in patients with severepreeclampsia // Blood. – 1989. - Sep;74(4). – P.1332-1338.
  18. Espana F., Gilabert J., Aznar J. Et al. Complexes of activated protein C with alpha 1-antitrypsin in normal pregnancy and in severe preeclampsia // Amer. J. Obstet. Gynecol.– 1991. – May; 164(5 Pt 1). – P.1310-1316.
  19. Fisher A., Tapon-Bretandiere I., Bros A., Josso F. Respective roles of ATIII and a2-macroglobylinin thrombin inactivation // Thromb. And Haemost. – 1981. – 45, №1. – P.51-54.
  20. Ishii A., Yamada S., Yamada R., Hamada H. T-PA activity in peripheral blood obtainedfrom pregnant women // J. Perinat. Med. – 1994. – 22(2). – P.113-117.
  21. 19. Korninger C. and Cllen D. Neutralization of human extrinsic (tissue-type)plasminogenactivator in human plasma: no evidence for a specific inhibitor // Thromb. Haemost.– 1981. – 46. – P. 662 – 665.
  22. 20. Kuller JA., Katz VL., McCoy MC., Bristow CL. Alpha 1-antitripsin deficiency andpregnancy // Amer. J. Perinatol. – 1995. – Sep; 12(5). – P.303-305.
  23. Lijnen H.R., Collen D. Alpha-2-antiplasmin In: PJD Publications Limited Box 966,Westbury. NY 11590, 1986. – P.225-283.
  24. Nakashima A., Kobayashi T., Terao T. Fibrinolysis during normal pregnancy andpreeclampsia relationships between plasma levels of plasminogen activators and inhibitorsGynecol. Obstet. Invest. – 1996. – 42(2). – P.95-101.
  25. Pinto S., Abbate R., Rostagno C. et al. Increased thrombin generation in normalpregnancy // Acta Eur. Fertil. – 1988. – Sep.-Oct; 19(5). – P.263-267
  26. Reverdiau-Moalic P., Gruel Y., Delahousse B. et al. Comparative study of the fibrinolyticsystem in human fetuses and in pregnant women // Thromb. Res. – 1991. – Mar;61(5-6). – P.489-499.
  27. Sakata Y. ,Loskutoff DJ., Gladson CL. et al. Mechanism of protein C – dependent clotlysis: role of plasminogen activator inhibitor // Blood. – 1986. – 68, №6. – P.12-18.
  28. Stegnar M., Zore A., Novak-Antolic Z. et al. Tissue-type plasminogen activator aftervenous occlusion in pregnancy and puerperium // Thromb. Haemost. – 1993. – Sep.1;70(3). – P.486-490.
  29. Teisner B., Davey MW., Grudzinskas JG. Circulating antithrombins in pregnancy //Brit. J. Obstet. Gynaecol. – 1982. – Jan; 89(1). – P.62-64.
  30. Travis J., Salvesen G. Control of coagulation and fibrinolysis by plasma proteinaseinhibitors // Behring. Inst. Mitt. – 1983. – Aug; (73). – P.56-65.
  31. 29. Van Werseh JW., Ubachs JM. Blood coagulation and fibrinilysis during normal pregnancy// Eur. J. Clin. Chem. Clin. Biochem. – 1991. – Jan; 29(1). – P.45-50.
  32. 30. Walker JE., Campbell DM., Ogston D. Blood levels of proteinase inhibitors in pregnancy// Brit. J. Obstet. Gynaecol. – 1982. – Mar; 89(3). – P.208-210.
  33. Wright JG., Cooper P., Astedt B. et al. Fibrinolysis during normal human pregnancy:complex inter-relationships between plasma levels of tissue plasminogen activator andinhibitors and the euglobulin clot lysis time // Brit. J. Haematol. - 1988. - Jun;69(2). – P.253-258.
  34. Yuasa S., Ishizawa M., Yuki Y. et al. Coagulation and fibrinolysis in pregnancy //Rinsho. Byori. – 1992. – 40(12). – P.1287-1291
© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.